Natco Pharma U.S. arm faces Fresenius complaint over diazepam injection prefilled syringe
Natco Pharma subsidiary in the U.S. is facing a complaint from global healthcare company Fresenius over marketing of Diazepam injection prefilled syringe in the country. “Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH have filed a complaint against Natco Pharma USA LLC [formerly known as Dash Pharmaceuticals LLC] in the District Court of Delaware…